Compare Vaxcyte Inc. Common Stock (PCVX) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Ross Stores, Inc. — how do they compare? Vaxcyte Inc. Common Stock trades at $67.16 (market cap $10.63B), while Ross Stores, Inc. trades at $237.35 (market cap $73.66B). The key difference: Ross Stores, Inc. is far larger — about 6.9× Vaxcyte Inc. Common Stock's market cap, and Ross Stores, Inc. pays a 0.77% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Ross Stores, Inc. for 48 Days on average.
| PCVX | ROST | |
|---|---|---|
Market Cap | $10.63B | $73.66B |
Volume | 1,525,205 | 1,784,732 |
Sector | Health | Consumer Cyclical |
52-Week High | $73.82 | $255.23 |
52-Week Low | $40.32 | $155.21 |
Typical Hold Time | 0 Days | 48 Days |
Enterprise Value | $9.26B | $74.11B |
Dividend Yield | — | 0.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ross Stores (ROST) trades at $225.68, down slightly by 0.07% on the day, with a bearish technical signal despite strong fundamental performance. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $2.66 exceeding the $1.95 forecast. Revenue growth continues with 2025 reaching $21.13B, while maintaining robust profitability with a 10.85% net income margin and exceptional 42.63% return on equity.
Wall Street maintains a bullish outlook with 64% buy ratings and a $274.14 consensus price target representing 21% upside potential. Key risks include competitive pressures in discount retail and potential margin compression from expansion costs. The stock's current technical weakness presents a potential entry point for investors confident in the company's store expansion strategy and value-focused merchandising approach.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
